Replies to post #2305 on GTC Biotherapeutics (fka GTCB)

[biopearl]

gym, GERN is my "other" holding. Anticancer agents that target telomerase look promising and of course their unsurpassed IP position in embryonic stem cell therapy stands alone. If you think there is a future there it is certainly worth more investigation. bp